ReproCELL, Inc. announces the establishment of a subsidiary

2014.01.28

The new subsidiary will accelerate R&D efforts and enhance our competitiveness in iPS cell and regenerative medicine segment, thereby contributing to future drug discovery and healthcare business generation. Click here for more information.